Hisham Hamadeh, Amgen, Inc., will deliver the 2013 In Vitro Lecture, “From Hazard Identification to Risk Assessment: Linking It Together with In Vitro Models” on Monday, March 11, 12:00 noon to 1:20 pm. This annual luncheon features important research using in vitro and alternative techniques to study basic mechanisms and to illustrate how these test methods benefit animal welfare by refining, reducing, and replacing animal use whenever it is feasible. Gaining insight to a molecule’s potential to cause harm to humans is a major challenge for scientists working in a variety of industries and disciplines including drug and chemical development as well as environmental protection. In vitro assays that can predict the potential clinical hazard in the absence of animal models are valuable not only for selecting more quality candidate drugs to advance, but also to reduce the number of animals consumed. Dr. Hamadeh will introduce this topic and participants will address specific questions at each table before resuming discussion among all the participants.
Thomas A. Lewandowksi, Education Committee Chair, Gradient, and Emily G. Notch, Dartmouth Medical School, are the chairpersons of this event that is hosted by the SOT Education Committee and sponsored by the Colgate-Palmolive Company.
Postdoctoral scholars, graduate students, undergraduates, and recipients of Colgate-Palmolive awards are among the guests at the In Vitro Toxicology Lecture and Luncheon. Students and postdoctoral scholars register for the limited tickets via the Annual Meeting registration, and the $10 deposit will be returned upon entry to the event. Senior toxicologists are invited directly to attend the event and serve as hosts at each of the tables.